| Literature DB >> 27257995 |
Ennio Tasciotti1, Fernando J Cabrera, Michael Evangelopoulos, Jonathan O Martinez, Usha R Thekkedath, Malgorzata Kloc, Rafik M Ghobrial, Xian C Li, Alessandro Grattoni, Mauro Ferrari.
Abstract
Transplantation is often the only choice many patients have when suffering from end-stage organ failure. Although the quality of life improves after transplantation, challenges, such as organ shortages, necessary immunosuppression with associated complications, and chronic graft rejection, limit its wide clinical application. Nanotechnology has emerged in the past 2 decades as a field with the potential to satisfy clinical needs in the area of targeted and sustained drug delivery, noninvasive imaging, and tissue engineering. In this article, we provide an overview of popular nanotechnologies and a summary of the current and potential uses of nanotechnology in cell and organ transplantation.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27257995 PMCID: PMC4961523 DOI: 10.1097/TP.0000000000001100
Source DB: PubMed Journal: Transplantation ISSN: 0041-1337 Impact factor: 4.939